Evidence map›Paper›PMID 24713855›Full record

ReviewAnnals of gastroenterology2012

Epidemiology of intrafamilial inflammatory bowel disease throughout Europe.

Maria Teresa Arias-Loste, Beatriz Castro, Montserrat Rivero, Javier Crespo

Abstract readReview
In one paragraph

Review in Annals of gastroenterology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maria Teresa Arias-LosteDepartment of Gastroenterology and Hepatology, Marques de Valdecilla University Hospital, IFIMAV, Santander, Spain.
Beatriz CastroDepartment of Gastroenterology and Hepatology, Marques de Valdecilla University Hospital, IFIMAV, Santander, Spain.
Montserrat RiveroDepartment of Gastroenterology and Hepatology, Marques de Valdecilla University Hospital, IFIMAV, Santander, Spain.
Javier CrespoDepartment of Gastroenterology and Hepatology, Marques de Valdecilla University Hospital, IFIMAV, Santander, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence and prevalence of inflammatory bowel disease (IBD) have distinctly changed over the past decades throughout Europe. From former North-South and West-East risk gradients, nowadays, classic high-risk areas for IBD in North and West present more stable incidences whereas in formerly low-risk zones the incidence is rising. These changes cannot be explained by genetic modifications in IBD patients' background, which draws attention to the possible existence of potent environmental factors triggering this epidemiologic shift. Important lessons can be drawn from different European population-based studies assessing the influence of environmental factors in familial IBD that may impact on the outcome of the disease and the management of the patients and their relatives.

Indexed as

environmental factorsepidemiologyfamilial aggregationinflammatory bowel disease

Identifiers

PMID24713855
PMCPMC3959374

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.